Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage
about
Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 11 October 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Chemoimmunotherapy with inotuz ...... stic leukemia in first salvage
@en
Chemoimmunotherapy with inotuz ...... stic leukemia in first salvage
@nl
type
label
Chemoimmunotherapy with inotuz ...... stic leukemia in first salvage
@en
Chemoimmunotherapy with inotuz ...... stic leukemia in first salvage
@nl
prefLabel
Chemoimmunotherapy with inotuz ...... stic leukemia in first salvage
@en
Chemoimmunotherapy with inotuz ...... stic leukemia in first salvage
@nl
P2093
P50
P356
P1433
P1476
Chemoimmunotherapy with inotuz ...... stic leukemia in first salvage
@en
P2093
Farhad Ravandi
Guillermo Garcia-Manero
Jan Burger
Jeffrey Jorgensen
Joseph Khoury
Jovitta Jacob
Kathryn Montalbano
Maria Khouri
Marina Konopleva
Nicholas J Short
P304
P356
10.1002/CNCR.31720
P407
P577
2018-10-11T00:00:00Z